| [1] |
赫捷， 陈万青. 2017中国肿瘤登记年报[M]. 北京: 人民卫生出版社, 2018.
|
| [2] |
Aleksandrova K, Pischon T, Jenab M, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study [J]. BMC Med, 2014, 12: 168.
|
| [3] |
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017 [J]. CA Cancer J Clin, 2017, 67(3): 177-193.
|
| [4] |
Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017 [J]. CA Cancer J Clin, 2017, 67(1): 7-30.
|
| [5] |
Kabat GC, Matthews CE, Kamensky V, et al. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study [J]. Am J Clin Nutr, 2015, 101(3): 558-569.
|
| [6] |
Song M, Giovannucci E. Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among White Adults in the United States [J]. JAMA Oncol, 2016, 2(9): 1154-1161.
|
| [7] |
王锡山. 结直肠肿瘤治疗的微创和功能外科理念在实践与探索中前行[J/CD]. 中华结直肠疾病电子杂志, 2013, 2(3): 106-108.
|
| [8] |
National Center for Health Statistics. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities [R]. Hyattsville (MD), 2016.
|
| [9] |
Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J]. N Engl J Med, 2004, 350(23): 2343-2351.
|
| [10] |
Wong RK, Tandan V, De Silva S, et al. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma [J]. Cochrane Database Syst Rev, 2007, (2): CD002102.
|
| [11] |
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer [J]. N Engl J Med, 2004, 351(17): 1731-1740.
|
| [12] |
Wancata LM, Banerjee M, Muenz DG, et al. Conditional survival in advanced colorectal cancer and surgery [J]. J Surg Res, 2016, 201(1): 196-201.
|
| [13] |
Chua TC, Saxena A, Chu F, et al. Predictors of cure after hepatic resection of colorectal liver metastases: an analysis of actual 5- and 10-year survivors [J]. J Surg Oncol, 2011, 103(8): 796-800.
|
| [14] |
Saltz LB, Clarke S, Diaz-Rubio E, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phaseⅢ study [J]. J Clin Oncol, 2008, 26(12): 2013-2019.
|
| [15] |
Duggan MA, Anderson WF, Altekruse S, et al. The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship [J]. Am J Surg Pathol, 2016, 40(12): e94-e102.
|